Genetické změny u neuroblastomů středního a vysokého rizika a jejich prognostický význam

Warning

This publication doesn't include Faculty of Education. It includes Faculty of Science. Official publication website can be found on muni.cz.
Title in English Genetic changes in high-risk and intermediate-risk neuroblastomas and their prognostic value
Authors

ŽEŽULKOVÁ Dita VRANOVÁ Vladimíra KUGLÍK Petr ŠTEFANČÍKOVÁ Lenka MAZÁNEK Pavel NEČESALOVÁ Eva FILKOVÁ Hana JAROŠOVÁ Marie VESELSKÁ Renata ŠTĚRBA Jaroslav

Year of publication 2007
Type Conference abstract
MU Faculty or unit

Faculty of Science

Citation
Description Neuroblastoma represents a type of tumor characterized by a strong genetic heterogeneity with specific genetic changes associated with different stages of the disease. Therefore, detection of genetic abnormalities in neuroblastoma is used (in combination with other prognostic factors) for stratification of patient treatment as well as for the control of a therapy effect. Since 1998, we analyzed 56 samples of tumor tissue taken from patients with neuroblastoma using I-FISH (all samples), CGH (37 samples) and array-CGH (3 samples). Gain 17q, amplification of MYCN gene, deletion 1p and deletion 11q were the most frequently identified genetic changes in this cohort. A high number of genetic changes was correlated with advanced stages (INSS stages 3-4) of the disease.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.